Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004630
Filing Date
2021-11-15
Accepted
2021-11-15 16:46:19
Documents
65
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tern-20210930.htm   iXBRL 10-Q 2771121
2 EX-10.1 tern-ex10_1.htm EX-10.1 36985
3 EX-31.1 tern-ex31_1.htm EX-31.1 18732
4 EX-31.2 tern-ex31_2.htm EX-31.2 18733
5 EX-32.1 tern-ex32_1.htm EX-32.1 11152
6 EX-32.2 tern-ex32_2.htm EX-32.2 11159
  Complete submission text file 0000950170-21-004630.txt   9817946

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tern-20210930_lab.xml EX-101.LAB 462072
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tern-20210930_pre.xml EX-101.PRE 348131
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tern-20210930.xsd EX-101.SCH 55348
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tern-20210930_cal.xml EX-101.CAL 50479
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tern-20210930_def.xml EX-101.DEF 199668
12 EXTRACTED XBRL INSTANCE DOCUMENT tern-20210930_htm.xml XML 1980559
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39926 | Film No.: 211411796
SIC: 2834 Pharmaceutical Preparations